Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
type: MedicalStudy
description: A Multi-National,Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin and Carboplatin Versus Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse (> 6 Months)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2005-04
end date: 2012-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00189553
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: ARCAGY/ GINECO GROUP
study subject: Ovarian Cancer
study subject: Fallopian Tube Cancer
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Ovarian Cancer
keywords: Fallopian Tube Cancer

AI Analytics
type: Organization